Xospata
Term · Oncology and biomedicine · MLC-T-ONC-009417
A drug used to treat adults with acute myeloid leukemia that came back or did not get better with other treatment and has a mutation (change) in the FLT3 gene. Xospata blocks certain proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called gilteritinib fumarate.
| Identifier | MLC-T-ONC-009417 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | gilteritinib fumarate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009417",
"term": "Xospata",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with acute myeloid leukemia that came back or did not get better with other treatment and has a mutation (change) in the FLT3 gene. Xospata blocks certain proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called gilteritinib fumarate.",
"synonyms": [
"gilteritinib fumarate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/xospata/"
}
Record 17,510 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.